Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Vogt-Koyanagi-Harada disease News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent case report details a patient with Vogt-Koyanagi-Harada disease experiencing progressive visual loss and multisystem involvement. This case highlights the complexities of diagnosing and managing this rare autoimmune condition.

A recent case report highlights a rare instance of immune checkpoint inhibitor-induced Vogt-Koyanagi-Harada-like disease, complicated by inflammatory macular neovascularization. This study contributes to the understanding of adverse effects associated with immune therapies.

Not rare diseases news,news about your rare disease.

Earlier

A recent case report details a patient with Vogt-Koyanagi-Harada disease experiencing progressive visual loss and multisystem involvement. This case highlights the complexities of diagnosing and managing this rare autoimmune condition.

A recent case report highlights a rare instance of immune checkpoint inhibitor-induced Vogt-Koyanagi-Harada-like disease, complicated by inflammatory macular neovascularization. This study contributes to the understanding of adverse effects associated with immune therapies.

Not rare diseases news,
news about your rare disease.